| Project/Area Number |
24890306
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Circulatory organs internal medicine
|
|---|
| Research Institution | National Cardiovascular Center Research Institute |
|---|
Principal Investigator |
NAGAI Chiaki 独立行政法人国立循環器病研究センター, 研究所, 流動研究員 (30633648)
|
|---|
| Project Period (FY) |
2012-08-31 – 2014-03-31
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | 心不全 / バイオマーカー / グライコプロテオーム解析 |
|---|
| Research Abstract |
To develop a therapeutic strategy for heart failure, a novel biomarker which enables to quantify the degree of the disease is highly required. In the present study, we aimed to identify a novel biomarker which could serve as a valuable supplement to the existing markers for more accurate diagnosis and prognosis of heart failure, using a glycoproteomic approach.
We first analyzed a glycosylation profile in the left ventricle of hypertension-induced rats during cardiac hypertrophy and heart failure, identifying altered glycan structures reflecting the degree of the disease. Our data also indicated that plasma enzymatic activity of a deglycosylation enzyme responsible for the characteristically altered glycosylation would be a novel biomarker for hypertrophy. In addition, glycoproteomic analysis targeting the left ventricle and plasma identified over 40 glycoproteins related to heart failure as biomarker candidates.
|
